<?xml version="1.0" encoding="utf-8"?>
<rss 
  version="2.0">
  <channel xmlns:dc="http://dublincore.org/documents/dcmi-namespace/" xmlns:media="http://search.yahoo.com/mrss/">
    <title>THC Biomed Intl Ltd.</title>
    <link>https://www.globenewswire.com/rssfeed/organization/i6S2AbfDaY1TIL4hcO6vlw==</link>
    <description>Contains the last 20 releases</description>
    <copyright>Copyright 2017, THC Biomed Intl Ltd.</copyright>
    <managingEditor>newsdesk@globenewswire.com (NewsDesk)</managingEditor>
    <lastBuildDate>Sat, 21 Jan 2017 00:07:40 GMT</lastBuildDate>
    <webMaster>webmaster@globenewswire.com (Webmaster)</webMaster>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2017/01/21/1078796/0/en/THC-Restates-Financial-Statements-to-Show-Reclassification-of-250-000-from-Income-to-Subscription-Funds.html</guid>
      <link>https://www.globenewswire.com/news-release/2017/01/21/1078796/0/en/THC-Restates-Financial-Statements-to-Show-Reclassification-of-250-000-from-Income-to-Subscription-Funds.html</link>
      <title>THC Restates Financial Statements to Show Reclassification of $250,000 from Income to Subscription Funds</title>
      <description><![CDATA[<p><span class="mw_region">VANCOUVER, BC</span><span>--(Marketwired - January 20, 2017) - </span><strong> </strong>THC BioMed Intl Ltd. ("<strong>THC</strong>" or the "<strong>Company</strong>") (<exchange name="CSE">CSE</exchange>: <ticker name="THC">THC</ticker>) (<exchange name="CSE">CSE</exchange>: <ticker name="THC.CN">THC.CN</ticker>) (<exchange name="CNSX">CNSX</exchange>: <ticker name="THC">THC</ticker>) (<exchange name="OTCQB">OTCQB</exchange>: <ticker name="THCBF">THCBF</ticker>) (<exchange name="FRANKFURT">FRANKFURT</exchange>: <ticker name="TFHC">TFHC</ticker>) announces that due to a request from Trans-Medica Ltd. ("Trans-Medica") in September 2016, it agreed to re-categorize, from income to subscription funds, an amount of money that had previously been received by THC from Trans-Medica. As a result, THC will restate its annual financial statements for the year ended July 31, 2016 and the financial quarters ended April and October 2016. While the $250,000 was initially received by THC pursuant to an invoice for services rendered and categorized as income, Trans-Medica contacted THC in the fall of 2016 to say that it had intended the funds to be used as subscription funds for shares at $0.25 each. Since the written agreement between the parties -- previously announced in press releases filed on May 14, 2015 and July 15, 2015 -- had allowed for that possibility, THC agreed in September 2016 to convert the amount into shares at $0.25. That price was available to the Issuer for the issuance of shares pursuant to CSE policy at the time. As a result, the Issuer will restate its financial statements to reflect that the money received was for subscription funds received in advance and not regular income.</p>]]></description>
      <pubDate>Sat, 21 Jan 2017 00:07 GMT</pubDate>
      <dc:identifier>1078796</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>THC Biomed Intl Ltd.</dc:contributor>
      <dc:modified>Fri, 22 Sep 2017 07:44 GMT</dc:modified>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2017/01/21/1078800/0/en/THC-BioMed-Begins-Shipping-Live-Cannabis-Plants-across-Canada-to-ACMPR-Registered-Patients-and-Announces-Wholesale-Genetic-Pricing.html</guid>
      <link>https://www.globenewswire.com/news-release/2017/01/21/1078800/0/en/THC-BioMed-Begins-Shipping-Live-Cannabis-Plants-across-Canada-to-ACMPR-Registered-Patients-and-Announces-Wholesale-Genetic-Pricing.html</link>
      <title>THC BioMed Begins Shipping Live Cannabis Plants across Canada to ACMPR Registered Patients and Announces Wholesale Genetic Pricing</title>
      <description><![CDATA[<p><span class="mw_region">VANCOUVER, BC</span><span>--(Marketwired - January 20, 2017) - </span> THC BioMed Intl Ltd. ("<strong>THC</strong>" or the "<strong>Company</strong>") (<exchange name="CSE">CSE</exchange>: <ticker name="THC">THC</ticker>) (<exchange name="CSE">CSE</exchange>: <ticker name="THC.CN">THC.CN</ticker>) (<exchange name="CNSX">CNSX</exchange>: <ticker name="THC">THC</ticker>) (<exchange name="OTCQB">OTCQB</exchange>: <ticker name="THCBF">THCBF</ticker>) (<exchange name="FRANKFURT">FRANKFURT</exchange>: <ticker name="TFHC">TFHC</ticker>) is pleased to announce that it has begun shipping live cannabis plants to patients registered under the ACMPR.</p>]]></description>
      <pubDate>Sat, 21 Jan 2017 00:06 GMT</pubDate>
      <dc:identifier>1078800</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>THC Biomed Intl Ltd.</dc:contributor>
      <dc:modified>Fri, 22 Sep 2017 07:44 GMT</dc:modified>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2016/12/20/1078792/0/en/Health-Canada-Issues-THC-BioMed-amendment-to-Sell-Starting-Materials-and-Grants-THC-Permission-to-Conduct-In-House-Analytical-Testing-THC-to-Expand-its-Facilities.html</guid>
      <link>https://www.globenewswire.com/news-release/2016/12/20/1078792/0/en/Health-Canada-Issues-THC-BioMed-amendment-to-Sell-Starting-Materials-and-Grants-THC-Permission-to-Conduct-In-House-Analytical-Testing-THC-to-Expand-its-Facilities.html</link>
      <title>Health Canada Issues THC BioMed amendment to Sell Starting Materials and Grants THC Permission to Conduct In-House Analytical Testing - THC to Expand its Facilities</title>
      <description><![CDATA[<p align="left"> <span class="mw_region">VANCOUVER, BC</span><span>--(Marketwired - December 20, 2016) - </span><strong> </strong>THC BioMed Intl Ltd. ("<strong>THC</strong>" or the "<strong>Company</strong>") (<exchange name="CSE">CSE</exchange>: <ticker name="THC">THC</ticker>) (<exchange name="CSE">CSE</exchange>: <ticker name="THC.CN">THC.CN</ticker>) (<exchange name="CNSX">CNSX</exchange>: <ticker name="THC">THC</ticker>) (<exchange name="OTCQB">OTCQB</exchange>: <ticker name="THCBF">THCBF</ticker>) (<exchange name="FRANKFURT">FRANKFURT</exchange>: <ticker name="TFHC">TFHC</ticker>) is pleased to announce several new developments relating to its new, amended license from Health Canada, the launch of its revamped website, the expansion of its facilities and changes in its work with Supra Research and Development Inc. ("<strong>Supra</strong>").</p>]]></description>
      <pubDate>Tue, 20 Dec 2016 13:00 GMT</pubDate>
      <dc:identifier>1078792</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>THC BioMed Intl Ltd.</dc:contributor>
      <dc:modified>Fri, 22 Sep 2017 07:44 GMT</dc:modified>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2016/11/23/1078789/0/en/THC-Lists-on-OTCQB.html</guid>
      <link>https://www.globenewswire.com/news-release/2016/11/23/1078789/0/en/THC-Lists-on-OTCQB.html</link>
      <title>THC Lists on OTCQB</title>
      <description><![CDATA[<p align="center" style="text-align:left"><span class="mw_region">VANCOUVER, BC</span><span>--(Marketwired - November 23, 2016) - </span>THC BioMed Intl Ltd. ("<strong>THC</strong>" or the "<strong>Company</strong>") (<exchange name="CSE">CSE</exchange>: <ticker name="THC">THC</ticker>) (<exchange name="CSE">CSE</exchange>: <ticker name="THC.CN">THC.CN</ticker>) (<exchange name="CNSX">CNSX</exchange>: <ticker name="THC">THC</ticker>) (<exchange name="OTCQB">OTCQB</exchange>: <ticker name="THCBF">THCBF</ticker>) (<exchange name="FRANKFURT">FRANKFURT</exchange>: <ticker name="TFHC">TFHC</ticker>) is pleased to announce that the Company's shares have been approved for listing on the OTCQB Marketplace and began trading on November 22, 2016. Real-Time Quote display for the Company's U.S. symbol "<strong>THCBF</strong>" is available at <a href="http://www.otcmarkets.com" rel="nofollow" title="www.otcmarkets.com">www.otcmarkets.com</a>.</p>]]></description>
      <pubDate>Wed, 23 Nov 2016 13:00 GMT</pubDate>
      <dc:identifier>1078789</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>THC Biomed Intl Ltd.</dc:contributor>
      <dc:modified>Fri, 22 Sep 2017 07:44 GMT</dc:modified>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2016/11/01/1078784/0/en/High-demand-for-Clone-Shipper-THC-Enters-into-Exclusive-Distribution-Agreement-with-Clone-Shipper.html</guid>
      <link>https://www.globenewswire.com/news-release/2016/11/01/1078784/0/en/High-demand-for-Clone-Shipper-THC-Enters-into-Exclusive-Distribution-Agreement-with-Clone-Shipper.html</link>
      <title>High demand for Clone Shipper; THC Enters into Exclusive Distribution Agreement with Clone Shipper</title>
      <description><![CDATA[<p align="left"> <span class="mw_region">VANCOUVER, BC</span><span>--(Marketwired - November 01, 2016) - </span>THC BioMed Intl Ltd. ("<strong>THC</strong>" or the "<strong>Company</strong>") (<exchange name="CSE">CSE</exchange>: <ticker name="THC">THC</ticker>) (<exchange name="CSE">CSE</exchange>: <ticker name="THC.CN">THC.CN</ticker>) (<exchange name="CNSX">CNSX</exchange>: <ticker name="THC">THC</ticker>) (<exchange name="OTC PINK">OTC PINK</exchange>: <ticker name="THCBF">THCBF</ticker>) (<exchange name="FRANKFURT">FRANKFURT</exchange>: <ticker name="TFHC">TFHC</ticker>) is pleased to announce that due to the high demand for Clone Shipper products, THC has entered into an exclusive agreement with Clone Shipper for the distribution rights for all of Canada. The two companies will continue to work toward an agreement for THC to purchase Clone Shipper, a U.S. based company, specializing in packaging products used to transport live plants. The distribution agreement is for a period of two years and THC paid Clone Shipper $75,000 for the rights.</p>]]></description>
      <pubDate>Tue, 01 Nov 2016 12:00 GMT</pubDate>
      <dc:identifier>1078784</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>THC Biomed Intl Ltd.</dc:contributor>
      <dc:modified>Fri, 22 Sep 2017 07:44 GMT</dc:modified>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2016/10/18/1078780/0/en/THC-BioMed-Receives-License-Amendment.html</guid>
      <link>https://www.globenewswire.com/news-release/2016/10/18/1078780/0/en/THC-BioMed-Receives-License-Amendment.html</link>
      <title>THC BioMed Receives License Amendment</title>
      <description><![CDATA[<p align="left"> <span class="mw_region">VANCOUVER, BC</span><span>--(Marketwired - October 18, 2016) - </span>THC BioMed Ltd. (<exchange name="CSE">CSE</exchange>: <ticker name="THC">THC</ticker>) (<exchange name="OTC PINK">OTC PINK</exchange>: <ticker name="THCBF">THCBF</ticker>) (<exchange name="FRANKFURT">FRANKFURT</exchange>: <ticker name="TFHC">TFHC</ticker>) ("<strong>THC</strong>" or the "<strong>Company</strong>") is pleased to report that it has had its license amended by Health Canada and will begin to initiate its business plan by inter-trading between licensed producers to strengthen its products and service.</p>]]></description>
      <pubDate>Tue, 18 Oct 2016 12:00 GMT</pubDate>
      <dc:identifier>1078780</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>THC Biomed Intl Ltd.</dc:contributor>
      <dc:modified>Fri, 22 Sep 2017 07:44 GMT</dc:modified>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2016/09/26/1078776/0/en/THC-Signs-LOI-to-Purchase-Clone-Shipper-for-1-Million-USD.html</guid>
      <link>https://www.globenewswire.com/news-release/2016/09/26/1078776/0/en/THC-Signs-LOI-to-Purchase-Clone-Shipper-for-1-Million-USD.html</link>
      <title>THC Signs LOI to Purchase Clone Shipper for 1 Million USD</title>
      <description><![CDATA[<p align="left"> <strong><span class="mw_region">VANCOUVER, BC</span><span>--(Marketwired - September 26, 2016) - </span></strong>THC BioMed Intl Ltd. ("<strong>THC</strong>" or the "<strong>Company</strong>")(CSE: THC)(OTC PINK: THCBF)(FRANKFURT: TFHC) is pleased to announce that it has signed an LOI to purchase 100% of Clone Shipper, a US based company, specializing in packaging products used to transport live plants, for 1 Million USD.</p>]]></description>
      <pubDate>Mon, 26 Sep 2016 12:00 GMT</pubDate>
      <dc:identifier>1078776</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>THC Biomed Intl Ltd.</dc:contributor>
      <dc:modified>Fri, 22 Sep 2017 07:44 GMT</dc:modified>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2016/05/24/1078772/0/en/Health-Canada-Grants-THC-BioMed-Oil-Production-License.html</guid>
      <link>https://www.globenewswire.com/news-release/2016/05/24/1078772/0/en/Health-Canada-Grants-THC-BioMed-Oil-Production-License.html</link>
      <title>Health Canada Grants THC BioMed Oil Production License</title>
      <description><![CDATA[<p><em><p>THC BioMed Successfully Imports 28 Dutch Cannabis Strains </p></em></p><p>
    <span class="mw_region">VANCOUVER, BC </span><span>--(Marketwired - May 24, 2016) - </span>THC BioMed Intl. Ltd. 
 (<exchange name="CSE">CSE</exchange>: <ticker name="THC">THC</ticker>) (<exchange name="OTC PINK">OTC PINK</exchange>: <ticker name="THCBF">THCBF</ticker>) (<exchange name="FRANKFURT">FRANKFURT</exchange>: <ticker name="TFHC">TFHC</ticker>) is pleased to announce that our wholly-owned subsidiary, THC BioMed Ltd. has been granted authorization by Health Canada to produce fresh marijuana, Cannabis Oil and Cannabis Resin.</p>]]></description>
      <pubDate>Tue, 24 May 2016 12:00 GMT</pubDate>
      <dc:identifier>1078772</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>THC Biomed Intl Ltd.</dc:contributor>
      <dc:modified>Fri, 22 Sep 2017 07:44 GMT</dc:modified>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2016/04/04/1078768/0/en/RETRANSMISSION-THC-BioMed-Enters-Agreement-for-Installation-of-Affinor-Vertical-Farming-System.html</guid>
      <link>https://www.globenewswire.com/news-release/2016/04/04/1078768/0/en/RETRANSMISSION-THC-BioMed-Enters-Agreement-for-Installation-of-Affinor-Vertical-Farming-System.html</link>
      <title>RETRANSMISSION: THC BioMed Enters Agreement for Installation of Affinor Vertical Farming System</title>
      <description><![CDATA[<p>
    <span class="mw_region">VANCOUVER, BC</span><span>--(Marketwired - April 04, 2016) - </span> </p>]]></description>
      <pubDate>Mon, 04 Apr 2016 14:35 GMT</pubDate>
      <dc:identifier>1078768</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>THC Biomed Intl Ltd.</dc:contributor>
      <dc:modified>Fri, 22 Sep 2017 07:44 GMT</dc:modified>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2016/04/04/1078764/0/en/THC-BioMed-Enters-Agreement-for-Installation-of-Affinor-Vertical-Farming-System.html</guid>
      <link>https://www.globenewswire.com/news-release/2016/04/04/1078764/0/en/THC-BioMed-Enters-Agreement-for-Installation-of-Affinor-Vertical-Farming-System.html</link>
      <title>THC BioMed Enters Agreement for Installation of Affinor Vertical Farming System</title>
      <description><![CDATA[<p>
    <span class="mw_region">VANCOUVER, BC</span><span>--(Marketwired - April 04, 2016) - </span> THC BioMed Intl Ltd. ("<strong>THC</strong>") (<exchange name="CSE">CSE</exchange>: <ticker name="THC">THC</ticker>)(<exchange name="OTC PINK">OTC PINK</exchange>: <ticker name="THCBF">THCBF</ticker>)(<exchange name="FRANKFURT">FRANKFURT</exchange>: <ticker name="TFHC">TFHC</ticker>) is pleased to announce it has entered into an agreement with Affinor Growers (<exchange name="CSE">CSE</exchange>: <ticker name="AFI">AFI</ticker>)(<exchange name="OTC PINK">OTC PINK</exchange>: <ticker name="RSSFF">RSSFF</ticker>)(<exchange name="FRANKFURT">FRANKFURT</exchange>: <ticker name="1AF">1AF</ticker>) ("<strong>Affinor</strong>") to install a vertical farming system in THC's medical marihuana facility in Kelowna, B.C.</p>]]></description>
      <pubDate>Mon, 04 Apr 2016 12:00 GMT</pubDate>
      <dc:identifier>1078764</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>THC Biomed Intl Ltd.</dc:contributor>
      <dc:modified>Fri, 22 Sep 2017 07:44 GMT</dc:modified>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2016/03/03/1078763/0/en/Zadar-Enters-Into-Lithium-Project-Option-Agreement.html</guid>
      <link>https://www.globenewswire.com/news-release/2016/03/03/1078763/0/en/Zadar-Enters-Into-Lithium-Project-Option-Agreement.html</link>
      <title>Zadar Enters Into Lithium Project Option Agreement</title>
      <description><![CDATA[<p><strong>VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 3, 2016) -</strong> Zadar Ventures Ltd. (the "Company" or "Zadar") (TSX VENTURE:ZAD)(FRANKFURT:ZAV)(OTC PINK:ZADDF) announces that it has entered into an Option Agreement (the "Option Agreement") with GeoXplor Corp. of Arizona to acquire a 100% interest in two prospective lithium projects near Silver Peak, Nevada in North America's only producing lithium brine basin, the Clayton Valley.</p>]]></description>
      <pubDate>Thu, 03 Mar 2016 13:00 GMT</pubDate>
      <dc:identifier>1078763</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Zadar Ventures Ltd.</dc:contributor>
      <dc:modified>Fri, 22 Sep 2017 07:44 GMT</dc:modified>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2016/02/24/1078760/0/en/Zadar-Receives-US-Listing.html</guid>
      <link>https://www.globenewswire.com/news-release/2016/02/24/1078760/0/en/Zadar-Receives-US-Listing.html</link>
      <title>Zadar Receives US Listing</title>
      <description><![CDATA[<p><strong>VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 24, 2016) -</strong> Zadar Ventures Ltd. (the "Company") (TSX VENTURE:ZAD)(FRANKFURT:ZAV)(OTC PINK:ZADDF) is pleased to announce that it has been approved to trade on the US OTCPK market under the symbol ZADDF. The company is currently preparing all the necessary paperwork to be OTCQB listed.</p>]]></description>
      <pubDate>Wed, 24 Feb 2016 14:00 GMT</pubDate>
      <dc:identifier>1078760</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Zadar Ventures Ltd.</dc:contributor>
      <dc:modified>Fri, 22 Sep 2017 07:44 GMT</dc:modified>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2016/02/22/1078758/0/en/Health-Canada-Grants-THC-BioMed-Licence-to-Cultivate-Marihuana.html</guid>
      <link>https://www.globenewswire.com/news-release/2016/02/22/1078758/0/en/Health-Canada-Grants-THC-BioMed-Licence-to-Cultivate-Marihuana.html</link>
      <title>Health Canada Grants THC BioMed Licence to Cultivate Marihuana</title>
      <description><![CDATA[<p><strong>VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 22, 2016) -</strong> THC BioMed Intl. Ltd. (CSE:THC)(OTC PINK:THCBF)(FRANKFURT:TFHC) is pleased to announce that our wholly-owned subsidiary, THC BioMed Ltd. has been granted a license to produce medical marihuana under Health Canada's Marihuana for Medical Purposes Regulations (MMPR).</p>]]></description>
      <pubDate>Mon, 22 Feb 2016 13:00 GMT</pubDate>
      <dc:identifier>1078758</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>THC Biomed Intl Ltd.</dc:contributor>
      <dc:modified>Fri, 22 Sep 2017 07:44 GMT</dc:modified>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2016/02/04/1078755/0/en/Zadar-Enters-Into-Lithium-Standstill-Agreement.html</guid>
      <link>https://www.globenewswire.com/news-release/2016/02/04/1078755/0/en/Zadar-Enters-Into-Lithium-Standstill-Agreement.html</link>
      <title>Zadar Enters Into Lithium Standstill Agreement</title>
      <description><![CDATA[<p><strong>VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 4, 2016) -</strong> Zadar Ventures Ltd. (the "Company") (TSX VENTURE:ZAD)(FRANKFURT:ZAV) announces that it has entered into a standstill agreement with a private Nevada LLC to negotiate an option to purchase a 100% interest in two prospective Lithium projects near Silver Peak, Nevada in North America's only producing lithium brine basin, the Clayton Valley Basin. </p>]]></description>
      <pubDate>Thu, 04 Feb 2016 13:00 GMT</pubDate>
      <dc:identifier>1078755</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Zadar Ventures Ltd.</dc:contributor>
      <dc:modified>Fri, 22 Sep 2017 07:44 GMT</dc:modified>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2015/12/10/1078751/0/en/THC-Closes-900-000-First-Tranche-Private-Placement-at-0-12-for-7-500-000-Units-and-Settles-90-600-in-Debt.html</guid>
      <link>https://www.globenewswire.com/news-release/2015/12/10/1078751/0/en/THC-Closes-900-000-First-Tranche-Private-Placement-at-0-12-for-7-500-000-Units-and-Settles-90-600-in-Debt.html</link>
      <title>THC Closes $900,000 First Tranche Private Placement at $0.12 for 7,500,000 Units and Settles $90,600 in Debt</title>
      <description><![CDATA[<p><strong>VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 10, 2015) -</strong> THC BioMed Intl Ltd. ("<strong>THC" or "the Company</strong>") (CSE:THC)(OTC PINK:THCBF)(FRANKFURT:TFHC) is pleased to announce the closing of the first tranche of a non-brokered private placement (the "<strong>Private Placement</strong>") in which THC has raised aggregate gross proceeds of $900,000. THC has issued 7,500,000 units (Each a "<strong>Unit</strong>") at a price of $0.12 per Unit. Each Unit is comprised of one common share and one common share purchase warrant exercisable at $0.25 per share for a period of 12 months, subject to an accelerated exercise provision that if the closing sales price of the Company's common shares is $0.20 or higher for a period of 10 consecutive trading days, then the Company may, within five days of such event, provide notice by way of press release to the holder of the warrants of the early expiry of the warrants, and thereafter the warrants shall expire on that date that is 30 days from the date that such notice is given.</p>]]></description>
      <pubDate>Thu, 10 Dec 2015 13:22 GMT</pubDate>
      <dc:identifier>1078751</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>THC Biomed Intl Ltd.</dc:contributor>
      <dc:modified>Fri, 22 Sep 2017 07:44 GMT</dc:modified>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2015/11/16/1078748/0/en/THC-Enters-LOI-to-Purchase-Health-Canada-Licensed-Cannabis-Testing-Laboratory.html</guid>
      <link>https://www.globenewswire.com/news-release/2015/11/16/1078748/0/en/THC-Enters-LOI-to-Purchase-Health-Canada-Licensed-Cannabis-Testing-Laboratory.html</link>
      <title>THC Enters LOI to Purchase Health Canada Licensed Cannabis Testing Laboratory</title>
      <description><![CDATA[<p><strong>VANCOUVER, BRITISH COLUMBIA--(Marketwired - Nov. 16, 2015) -</strong> THC BioMed Intl Ltd. (CSE:THC)(FRANKFURT:TFHC)(OTC PINK:THCBF) ("THC enters LOI to purchase Health Canada Licensed Cannabis Testing Laboratory"). ("Applies for supplementary license to Produce and sell fresh marijuana and cannabis oil")</p>]]></description>
      <pubDate>Mon, 16 Nov 2015 21:29 GMT</pubDate>
      <dc:identifier>1078748</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>THC Biomed Intl Ltd.</dc:contributor>
      <dc:modified>Fri, 22 Sep 2017 07:44 GMT</dc:modified>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2015/09/01/1078746/0/en/THC-BioMed-Corporate-Update.html</guid>
      <link>https://www.globenewswire.com/news-release/2015/09/01/1078746/0/en/THC-BioMed-Corporate-Update.html</link>
      <title>THC BioMed Corporate Update</title>
      <description><![CDATA[<p><strong>VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 1, 2015) -</strong> THC BioMed Intl Ltd. (CSE:THC)(FRANKFURT:TFHC)(OTC PINK:THCBF) ("<strong>THC</strong>") is pleased to provide its shareholders with a Corporate update. The company would like to advise that Health Canada inspectors have conducted a second pre-licensing inspection on August 20, 2015 at its THC BioMed Ltd facility located in Kelowna BC. Upon completion of the inspection there were no further deficiencies indicated.</p>]]></description>
      <pubDate>Tue, 01 Sep 2015 12:00 GMT</pubDate>
      <dc:identifier>1078746</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>THC BioMed Intl Ltd.</dc:contributor>
      <dc:modified>Fri, 22 Sep 2017 07:44 GMT</dc:modified>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2015/07/29/1078743/0/en/THC-BioMed-Announces-J-D-Springett-Joins-Advisory-Board.html</guid>
      <link>https://www.globenewswire.com/news-release/2015/07/29/1078743/0/en/THC-BioMed-Announces-J-D-Springett-Joins-Advisory-Board.html</link>
      <title>THC BioMed Announces J.D. Springett Joins Advisory Board</title>
      <description><![CDATA[<p><strong>VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 29, 2015) -</strong> THC BioMed Intl Ltd. ("<strong>THC</strong>") (CSE:THC)(OTC PINK:THCBF)(FRANKFURT:TFHC) is pleased to announce it has appointed Mr. J. D. Springett to the company's newly formed advisory board. Mr. Springett brings 7 years' experience in the newly emerging Medical Cannabis industry, beginning with Cannabis Science in 2008. He has extensive knowledge and experience in the medical marijuana sector and is highly sought after as a design and training expert for licensed medical marijuana facilities. He has been a valuable consultant for several companies seeking a MMPR license. Mr. Springett will be a valuable addition to our highly trained scientific consulting team.</p>]]></description>
      <pubDate>Wed, 29 Jul 2015 12:00 GMT</pubDate>
      <dc:identifier>1078743</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>Thelon Capital Ltd.</dc:contributor>
      <dc:modified>Fri, 22 Sep 2017 07:44 GMT</dc:modified>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2015/07/22/1078741/0/en/Don-Shaxon-Joins-Advisory-Board-of-THC-BioMed-Intl-Ltd.html</guid>
      <link>https://www.globenewswire.com/news-release/2015/07/22/1078741/0/en/Don-Shaxon-Joins-Advisory-Board-of-THC-BioMed-Intl-Ltd.html</link>
      <title>Don Shaxon Joins Advisory Board of THC BioMed Intl Ltd.</title>
      <description><![CDATA[<p><strong>VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 22, 2015) -</strong> THC BioMed Intl Ltd. ("<strong>THC</strong>") (CSE:THC)(OTC PINK:THCBF)(FRANKFURT:TFHC) is pleased to announce it has appointed Don Shaxon to the Company's newly formed Advisory Board. Mr. Shaxon brings 20 years' experience in the capital markets including a successful position as Corporate Development Manager with Cannabis Science Inc., where he was instrumental in helping build the company from a small cap company into an industry leader with a market cap that topped $100 million.</p>]]></description>
      <pubDate>Wed, 22 Jul 2015 12:00 GMT</pubDate>
      <dc:identifier>1078741</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>THC BioMed Intl Ltd.</dc:contributor>
      <dc:modified>Fri, 22 Sep 2017 07:44 GMT</dc:modified>
    </item>
    <item>
      <guid
        isPermaLink="true">https://www.globenewswire.com/news-release/2015/07/16/1078739/0/en/THC-BioMed-Executes-Definitive-Agreement.html</guid>
      <link>https://www.globenewswire.com/news-release/2015/07/16/1078739/0/en/THC-BioMed-Executes-Definitive-Agreement.html</link>
      <title>THC BioMed Executes Definitive Agreement</title>
      <description><![CDATA[<p><strong>VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 16, 2015) -</strong> THC BioMed Intl Ltd. ("<strong>THC</strong>") (CSE:THC)(OTC PINK:THCBF)(FRANKFURT:TFHC) is pleased to announce it has Executed a Definitive agreement, as per the terms of the Binding Letter Agreement announced May 15<sup>th</sup> 2015, (the "<strong>Agreement</strong>") with Trans-Medica Ltd. ("<strong>Trans-Medica</strong>"), to provide consulting services and utilize Trans-Medica's proprietary Vertical Grow System for total consideration to THC of $700,000. </p>]]></description>
      <pubDate>Thu, 16 Jul 2015 12:00 GMT</pubDate>
      <dc:identifier>1078739</dc:identifier>
      <dc:language>en</dc:language>
      <dc:publisher>GlobeNewswire Inc.</dc:publisher>
      <dc:contributor>THC BioMed Intl Ltd.</dc:contributor>
      <dc:modified>Fri, 22 Sep 2017 07:44 GMT</dc:modified>
    </item>
  </channel>
</rss>